All In Biotech

Drug Trial Radar · NCT07830732

A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A

A Multinational, Open-label Study to Investigate Efficacy and Safety of Denecimig (Mim8) in Adults With Acquired Haemophilia A

Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

84

Planned (sponsor's estimate)

Start

Oct 16, 2026

Primary completion

Mar 23, 2029

Study completion Mar 23, 2029

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Sep 21, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to find out if denecimig is safe and effective for treating people who have acquired haemophilia A. Participants will be in this study for up to around 1 year and 5 months (73 week).

Conditions

  • Haemophilia A

Interventions

  • DenecimigDrug

    Participants will receive subcutaneous (s.c.) injections of denecimig.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of treated bleedsTime frame: From treatment initiation (week 0) until end of main part (week 12)

Locations

83 sites in 18 countries. Site status is shown where the registry gives one.

  • University of Iowa_Iowa City

    Iowa City, Iowa · Not yet recruiting

  • Tulane University School of Medicine

    Metairie, Louisiana · Not yet recruiting

  • University of Minnesota

    Minneapolis, Minnesota · Not yet recruiting

  • Mayo Clinic

    Rochester, Minnesota · Not yet recruiting

  • Washington University

    St Louis, Missouri · Recruiting

  • University of North Carolina

    Chapel Hill, North Carolina · Not yet recruiting

  • Duke University_Durham

    Durham, North Carolina · Not yet recruiting

  • University of Oklahoma Health

    Oklahoma City, Oklahoma · Not yet recruiting

  • Penn State MS Hershey Med Ctr

    Hershey, Pennsylvania · Not yet recruiting

  • Univ of Pennsylvania Hospital

    Philadelphia, Pennsylvania · Not yet recruiting

  • UT Southwestern

    Dallas, Texas · Not yet recruiting

  • Univ Texas HSC-Houston

    Houston, Texas · Not yet recruiting

  • UT Health San Antonio

    San Antonio, Texas · Not yet recruiting

  • University of Utah Health

    Salt Lake City, Utah · Not yet recruiting

  • University of Vermont Med Ctr

    Burlington, Vermont · Not yet recruiting

  • University of Virginia

    Charlottesville, Virginia · Not yet recruiting

  • Virginia Cwealth Univ Richmond

    Richmond, Virginia · Not yet recruiting

  • Washington Ctr Bleed Disorder

    Seattle, Washington · Not yet recruiting

  • Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich

    Buenos Aires, Argentina · Not yet recruiting

  • Servicio de Hematologia - Hospital Italiano

    Buenos Aires, Argentina · Not yet recruiting

  • Instituto de Hematologia DR.Ruben Davoli

    Rosario, Santa Fe Province, Argentina · Not yet recruiting

  • Royal Prince Alfred Hospital - Department of Haematology

    Camperdown, New South Wales, Australia · Not yet recruiting

  • Royal Brisbane and Women's Hospital - Integrated Cancer Research (I-CARE)

    Herston, Queensland, Australia · Not yet recruiting

  • The Alfred - Cancer Trials

    Melbourne, Victoria, Australia · Not yet recruiting

  • Hemorio-Fundarj

    Rio de Janeiro, Brazil · Not yet recruiting

  • Hospital Samaritano Higienópolis - Instituto de Conhecimento Ensino e Pesquisa (ICEP)

    São Paulo, Brazil · Not yet recruiting

  • Hemocentro UNICAMP

    Distrito de Barão Geraldo - Campinas, São Paulo, Brazil · Not yet recruiting

  • Unidade de Pesquisa Clínica do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo

    Ribeirão Preto, São Paulo, Brazil · Not yet recruiting

  • Hospital das Clínicas da Faculdade de Medicina da USP

    São Paulo, São Paulo, Brazil · Not yet recruiting

  • St Pauls Hospital

    Vancouver, British Columbia, Canada · Not yet recruiting

  • McMaster University

    Hamilton, Ontario, Canada · Not yet recruiting

  • St. Michael's Hospital

    Toronto, Ontario, Canada · Not yet recruiting

  • Skejby Blodsygdomme, blødercentret

    Aarhus N, Denmark · Not yet recruiting

  • HCL - HOPITAL LOUIS PRADEL - Unité d'hémostase Clinique

    Bron, France · Not yet recruiting

  • HOPITAL DE BICETRE_Centre de l'Hémophilie

    Le Kremlin-Bicêtre, France · Not yet recruiting

  • INSTITUT COEUR POUMON_Service d'hémostase et transfusion

    Lille, France · Not yet recruiting

  • CHU DE NANTES-HOPITAL HOTEL-DIEU_Centre régional de traitement de l'Hémophilie

    Nantes, France · Not yet recruiting

  • Vivantes Netzwerk für Gesundheit GmbH - Vivantes Klinikum im Friedrichshain

    Berlin, Germany · Not yet recruiting

  • Universitätsklinikum Bonn - Institut für Experimentelle Hämatologie

    Bonn, Germany · Not yet recruiting

  • Medizinische Hochschule Hannover - Hämatologie, Hämostaseologie, Onkologie

    Hanover, Germany · Not yet recruiting

Showing 40 of 83 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.